Arima H, Takahashi M, Aramaki Y, Sakamoto T, Yuda K, Akiyama K, Goto T, Tsuchiya S
School of Pharmacy, Tokyo University of Pharmacy and Life Science, Hachioji, Japan.
Pharm Res. 1999 Aug;16(8):1163-71. doi: 10.1023/a:1018964625977.
The two objectives of this study were to design potent phosphorothioate antisense oligonucleotides (AS-S-oligos) directed against the human interleukin-10 (IL-10) gene product and to reveal the DNA sequence which best activates antisense effects.
The design of potent AS-S-oligo was performed by using melting temperature (Tm) value of a DNA/RNA hybrid calculated by the nearest neighbor method and a secondary structure of human IL-10 mRNA suggested by RNA folding algorithms. U937 cells were used to estimate the antisense effect of the AS-S-oligos.
Of the eight candidates selected as potent AS-S-oligos on the basis of having higher Tm values and favorable secondary structures of the IL-10 mRNA, AS-S-oligos directed against the translated (AS367-S-oligo) and 3'-untranslated (AS637-S-oligo) region of IL-10 mRNA showed the strongest inhibitory effects on IL-10 production and this inhibition was dose- and time-dependent. Reverse transcription-polymerase chain reaction (RT-PCR) revealed that the antisense effects of AS-S-oligos originated from a specific reduction of target IL-10 mRNA by hybridization with AS367- and AS637-S-oligos. In addition, these AS-S-oligos did not affect human tumor necrosis factor-alpha (TNF-alpha) production in the cells stimulated by lipopolysaccharide (LPS). Strong positive correlations between the inhibitory effect of AS-S-oligos on the IL-10 production and not only Tm values calculated by nearest neighbor method but also Tm values determined by absorbance versus temperature profiles were demonstrated except for AS25-S-oligo and AS1249-S-oligo.
These findings suggest AS367- and AS637-S-oligos powerfully inhibit IL-10 production in U937 cells via an antisense mechanism. In addition, it is suggested efficiency of AS-S-oligo directed against the sequence of the target gene product can be explained by these Tm values and the proposed secondary structures of the target gene product.
本研究的两个目标是设计针对人白细胞介素10(IL-10)基因产物的高效硫代磷酸酯反义寡核苷酸(AS-S-寡核苷酸),并揭示最能激活反义效应的DNA序列。
通过使用最近邻法计算的DNA/RNA杂交熔解温度(Tm)值以及RNA折叠算法推测的人IL-10 mRNA二级结构来设计高效AS-S-寡核苷酸。使用U937细胞评估AS-S-寡核苷酸的反义效应。
基于具有较高的Tm值和IL-10 mRNA的有利二级结构而被选为高效AS-S-寡核苷酸的八个候选物中,针对IL-10 mRNA翻译区(AS367-S-寡核苷酸)和3'-非翻译区(AS637-S-寡核苷酸)的AS-S-寡核苷酸对IL-10产生显示出最强的抑制作用,并且这种抑制是剂量和时间依赖性的。逆转录-聚合酶链反应(RT-PCR)显示,AS-S-寡核苷酸的反义效应源于与AS367-和AS637-S-寡核苷酸杂交导致靶IL-10 mRNA的特异性减少。此外,这些AS-S-寡核苷酸不影响脂多糖(LPS)刺激的细胞中人肿瘤坏死因子-α(TNF-α)的产生。除了AS25-S-寡核苷酸和AS1249-S-寡核苷酸外,还证明了AS-S-寡核苷酸对IL-10产生的抑制作用与不仅通过最近邻法计算的Tm值而且与通过吸光度对温度曲线确定的Tm值之间存在强正相关。
这些发现表明AS367-和AS637-S-寡核苷酸通过反义机制强烈抑制U937细胞中IL-10的产生。此外,提示针对靶基因产物序列的AS-S-寡核苷酸的效率可以通过这些Tm值和所提出的靶基因产物二级结构来解释。